{"id":"https://openalex.org/W2997249644","doi":"https://doi.org/10.2174/1871520620666200101150640","title":"The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib","display_name":"The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib","publication_year":2020,"publication_date":"2020-01-02","ids":{"openalex":"https://openalex.org/W2997249644","doi":"https://doi.org/10.2174/1871520620666200101150640","mag":"2997249644","pmid":"https://pubmed.ncbi.nlm.nih.gov/31893998"},"language":"en","primary_location":{"id":"doi:10.2174/1871520620666200101150640","doi":"https://doi.org/10.2174/1871520620666200101150640","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871520620666200101150640","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102766787","display_name":"Mitra Korani","orcid":"https://orcid.org/0000-0001-6137-5082","observed_orcids":["https://orcid.org/0000-0001-6137-5082"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mitra Korani","raw_affiliation_strings":["Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045230308","display_name":"Sara Nikoofal\u2010Sahlabadi","orcid":"https://orcid.org/0000-0001-8619-654X","observed_orcids":["https://orcid.org/0000-0001-8619-654X"]},"institutions":[{"id":"https://openalex.org/I4210128695","display_name":"Hormozgan University of Medical Sciences","ror":"https://ror.org/037wqsr57","country_code":"IR","type":"education","lineage":["https://openalex.org/I4210128695"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Sara Nikoofal-Sahlabadi","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran","institution_ids":["https://openalex.org/I4210128695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017947632","display_name":"Amin Reza Nikpoor","orcid":"https://orcid.org/0000-0001-5619-8771","observed_orcids":["https://orcid.org/0000-0001-5619-8771"]},"institutions":[{"id":"https://openalex.org/I4210128695","display_name":"Hormozgan University of Medical Sciences","ror":"https://ror.org/037wqsr57","country_code":"IR","type":"education","lineage":["https://openalex.org/I4210128695"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Amin R. Nikpoor","raw_affiliation_strings":["Department of Immunology, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran","institution_ids":["https://openalex.org/I4210128695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091255856","display_name":"Solmaz Ghaffari","orcid":"https://orcid.org/0000-0002-5166-5112","observed_orcids":["https://orcid.org/0000-0002-5166-5112"]},"institutions":[{"id":"https://openalex.org/I110525433","display_name":"Islamic Azad University, Tehran","ror":"https://ror.org/01kzn7k21","country_code":"IR","type":"education","lineage":["https://openalex.org/I110525433"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Solmaz Ghaffari","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran","institution_ids":["https://openalex.org/I110525433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113495709","display_name":"Hossein Attar","orcid":"https://orcid.org/0000-0001-9357-6460","observed_orcids":["https://orcid.org/0000-0001-9357-6460"]},"institutions":[{"id":"https://openalex.org/I110525433","display_name":"Islamic Azad University, Tehran","ror":"https://ror.org/01kzn7k21","country_code":"IR","type":"education","lineage":["https://openalex.org/I110525433"]},{"id":"https://openalex.org/I155419210","display_name":"Islamic Azad University, Science and Research Branch","ror":"https://ror.org/03187yj51","country_code":"IR","type":"education","lineage":["https://openalex.org/I110525433","https://openalex.org/I155419210"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Hossein Attar","raw_affiliation_strings":["Chemical Engineering Department, Engineering and Technology Faculty, Sciences and Research Branch, Islamic Azad University, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Engineering Department, Engineering and Technology Faculty, Sciences and Research Branch, Islamic Azad University, Tehran, Iran","institution_ids":["https://openalex.org/I110525433","https://openalex.org/I155419210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029572002","display_name":"Mohammad Mashreghi","orcid":"https://orcid.org/0000-0002-5197-6260","observed_orcids":["https://orcid.org/0000-0002-5197-6260"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mohammad Mashreghi","raw_affiliation_strings":["Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":"https://orcid.org/0000-0002-5197-6260","affiliations":[{"raw_affiliation_string":"Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048139853","display_name":"Mahmoud Reza Jaafari","orcid":"https://orcid.org/0000-0003-3908-6828","observed_orcids":["https://orcid.org/0000-0003-3908-6828"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":true,"raw_author_name":"Mahmoud R. Jaafari","raw_affiliation_strings":["Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5048139853"],"corresponding_institution_ids":["https://openalex.org/I165560825"],"apc_list":null,"apc_paid":null,"fwci":0.6659,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.53803664,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"20","issue":"6","first_page":"700","last_page":"708"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9769999980926514},{"id":"https://openalex.org/keywords/liposomal-drug-delivery","display_name":"liposomal drug delivery","score":0.9190000295639038},{"id":"https://openalex.org/keywords/phase-transition-temperature","display_name":"phase transition temperature","score":0.9049999713897705},{"id":"https://openalex.org/keywords/dipalmitoylphosphatidylcholine","display_name":"DPPC","score":0.9049999713897705},{"id":"https://openalex.org/keywords/hematopoietic-stem-and-progenitor-cells","display_name":"hematopoietic stem and progenitor cells","score":0.9919999837875366},{"id":"https://openalex.org/keywords/drug-release-profile","display_name":"drug release profile","score":0.5410000085830688},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7730000019073486},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8180000185966492},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.4970000088214874},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7429999709129333},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.8824102878570557},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.7768407464027405},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6496617197990417},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.60406094789505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5585960149765015},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4937179982662201},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4694494903087616},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4235304594039917},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.4102880358695984},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.36681586503982544},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.349809467792511},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34614297747612},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.2913670539855957},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17033499479293823},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15449616312980652},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13841229677200317},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D041681","descriptor_name":"NIH 3T3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044366","descriptor_name":"Transition Temperature","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044367","descriptor_name":"Phase Transition","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1871520620666200101150640","doi":"https://doi.org/10.2174/1871520620666200101150640","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871520620666200101150640","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:31893998","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31893998","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer agents in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8782931428","display_name":null,"funder_award_id":"930761","funder_id":"https://openalex.org/F4320322855","funder_display_name":"Mashhad University of Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320322855","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W366249503","https://openalex.org/W1551500444","https://openalex.org/W1585705786","https://openalex.org/W1839039174","https://openalex.org/W1976505462","https://openalex.org/W1978710394","https://openalex.org/W1978735501","https://openalex.org/W1979343074","https://openalex.org/W1980422006","https://openalex.org/W1982650056","https://openalex.org/W1990983926","https://openalex.org/W1995566893","https://openalex.org/W2000781567","https://openalex.org/W2008138421","https://openalex.org/W2013470095","https://openalex.org/W2024007204","https://openalex.org/W2024182029","https://openalex.org/W2039374629","https://openalex.org/W2047794102","https://openalex.org/W2050271125","https://openalex.org/W2051925512","https://openalex.org/W2052032313","https://openalex.org/W2052840623","https://openalex.org/W2061510929","https://openalex.org/W2063338965","https://openalex.org/W2071997614","https://openalex.org/W2074049796","https://openalex.org/W2074789428","https://openalex.org/W2093353574","https://openalex.org/W2103184797","https://openalex.org/W2108522140","https://openalex.org/W2117184453","https://openalex.org/W2117697469","https://openalex.org/W2121805411","https://openalex.org/W2131438308","https://openalex.org/W2134102124","https://openalex.org/W2148928274","https://openalex.org/W2154343997","https://openalex.org/W2188775408","https://openalex.org/W2313479778","https://openalex.org/W2599276599","https://openalex.org/W2887567490","https://openalex.org/W2891009951","https://openalex.org/W2891469969","https://openalex.org/W2919645637","https://openalex.org/W2945311898","https://openalex.org/W4213030902","https://openalex.org/W4232191614"],"related_works":["https://openalex.org/W2945311898","https://openalex.org/W4253745085","https://openalex.org/W2947193370","https://openalex.org/W4389051577","https://openalex.org/W366249503","https://openalex.org/W2188775408","https://openalex.org/W3126695924","https://openalex.org/W3003598627","https://openalex.org/W854052258","https://openalex.org/W4400554026"],"abstract_inverted_index":{"AIMS:":[0],"Here,":[1],"three":[2,144,184,238],"liposomal":[3,44,134,146,156,186,239],"formulations":[4,52,147,187,222,240,277,340],"of":[5,21,51,76,86,100,132,148,220,246,293,303,315,362],"DPPC/DPPG/Chol/DSPE-mPEG2000":[6],"(F1),":[7],"DPPC/DPPG/Chol":[8],"(F2)":[9],"and":[10,17,28,48,57,80,96,121,142,161,190,196,249,254,305,357,364],"HSPC/DPPG/Chol/DSPE-mPEG2000":[11],"(F3)":[12],"encapsulating":[13],"BTZ":[14,41,87,104,149,363],"were":[15,53,166,232],"prepared":[16,341],"characterized":[18],"in":[19,55,58,60,105,125,226,282,300,328,331,352],"terms":[20],"their":[22],"size,":[23],"surface":[24],"charge,":[25],"drug":[26,108],"loading,":[27],"release":[29],"profile.":[30],"Mannitol":[31],"was":[32,178,209,223],"used":[33,211],"as":[34,168,212],"a":[35,106,213,242,313],"trapping":[36],"agent":[37],"to":[38,140,268,284,309,345,349],"entrap":[39],"the":[40,43,74,92,101,183,194,237,354,359],"inside":[42],"core.":[45],"The":[46,83,217,257],"cytotoxicity":[47,176,272],"anti-tumor":[49,130,298],"activity":[50,131],"investigated":[54],"vitro":[56,175,271],"vivo":[59],"mice":[61,227,301,321],"bearing":[62],"tumor.":[63],"BACKGROUND:":[64],"Bortezomib":[65],"(BTZ)":[66],"is":[67],"an":[68],"FDA":[69],"approved":[70],"proteasome":[71],"inhibitor":[72],"for":[73,91,182,251],"treatment":[75],"mantle":[77],"cell":[78,207,215],"lymphoma":[79],"multiple":[81],"myeloma.":[82],"low":[84,97],"solubility":[85],"has":[88],"been":[89],"responsible":[90],"several":[93],"side":[94,355],"effects":[95,356],"therapeutic":[98,122,218,360],"efficacy":[99,219,245,299,361],"drug.":[102],"Encapsulating":[103],"nano":[107],"delivery":[109,123],"system;":[110],"helps":[111],"overcome":[112],"such":[113],"issues.":[114],"Among":[115],"NDDSs,":[116],"liposomes":[117,261,311],"are":[118,193],"promising":[119],"diagnostic":[120],"vehicles":[124],"cancer":[126,198],"treatment.":[127],"OBJECTIVE:":[128],"Evaluating":[129],"bortezomib":[133],"formulations.":[135],"METHODS:":[136],"Data":[137],"prompted":[138],"us":[139],"design":[141],"develop":[143],"different":[145],"based":[150],"on":[151,188],"Tm":[152,292,314,343],"parameter,":[153],"which":[154,192],"determines":[155],"stiffness.":[157],"DPPC":[158],"(Tm":[159,163],"41\u00b0C)":[160],"HSPC":[162],"55\u00b0C)":[164],"lipids":[165],"chosen":[167],"variables":[169],"associated":[170],"with":[171,241,288,312,324,342],"liposome":[172],"rigidity.":[173],"In":[174,270],"assay":[177],"then":[179],"carried":[180],"out":[181],"designed":[185],"C26":[189,304],"B16F0,":[191],"colon":[195],"melanoma":[197],"mouse-cell":[199],"lines,":[200],"respectively.":[201,256],"NIH":[202],"3T3":[203],"mouse":[204],"embryonic":[205],"fibroblast":[206],"line":[208],"also":[210,319],"normal":[214],"line.":[216],"these":[221],"further":[224,366],"assessed":[225],"tumor":[228],"models.":[229],"RESULT:":[230],"MBTZ":[231],"successfully":[233],"encapsulated":[234],"into":[235],"all":[236],"high":[243],"entrapment":[244],"60,":[247],"64,":[248],"84%":[250],"F1,":[252],"F2,":[253],"F3,":[255],"findings":[258,336],"showed":[259,274,295],"that":[260,275,338],"mean":[262],"particle":[263],"diameter":[264],"ranged":[265],"from":[266],"103.4":[267],"146.8nm.":[269],"studies":[273],"liposomal-BTZ":[276],"had":[278],"higher":[279,297],"IC50":[280],"value":[281],"comparison":[283],"free":[285],"BTZ.":[286],"F2-liposomes":[287],"DPPC,":[289],"having":[290],"lower":[291],"41\u00b0C,":[294],"much":[296],"models":[302],"B16F0":[306],"tumors":[307],"compared":[308,323],"F3-HSPC":[310],"55\u00b0C.":[316],"F2":[317],"formulation":[318],"enhanced":[320],"survival":[322],"untreated":[325],"groups,":[326],"either":[327],"BALB/c":[329],"or":[330],"C57BL/6":[332],"mice.":[333],"CONCLUSION:":[334],"Our":[335],"indicated":[337],"F2-DPPC-liposomal":[339],"close":[344],"body":[346],"temperature":[347],"seem":[348],"be":[350],"effective":[351],"reducing":[353],"increasing":[358],"merits":[365],"investigation.":[367]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-01-10T00:00:00"}